ZURA — Zura Bio Cashflow Statement
0.000.00%
- $93.67m
- -$69.62m
- 45
- 44
- 15
- 27
Annual cashflow statement for Zura Bio, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | |
Standards: | — | USG | USG | USG | USG |
Status: | fx Preliminary | Final | Final | Final | Final |
Net Income/Starting Line | — | 6.85 | 3.55 | -60.6 | -52.4 |
Depreciation | |||||
Non-Cash Items | — | -7.71 | -6.22 | 40.4 | 22 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | — | -0.236 | 1.6 | 5.12 | 2.31 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | — | -1.1 | -1.07 | -15.1 | -28.1 |
Capital Expenditures | — | — | — | -8 | -5.08 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | -139 | 0 | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | -139 | 0 | -8 | -5.08 |
Financing Cash Flow Items | — | 141 | 0 | -1.18 | -0.944 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | — | 141 | 0.356 | 121 | 110 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | — | 0.729 | -0.715 | 98.2 | 76.7 |